The prognosis from a CPG5 cancer is considered very poor if left untreated. Treatment is strongly recommended to reduce the risk that the cancer may spread (metastasis) or cause death.
The National Institute for Health and Care Excellence currently recommends that men diagnosed with CPG5 cancer are offered treatment with the intention of cure. Active surveillance is not recommended.
This, however, depends on how old you are, your general state of health and your other medical conditions.
Based on the NICE recommendations you are likely to be offered:
Based on the NICE recommendations you may be asked to consider:
